Studies with excitatory amino acid antagonists in rat CNS: 2-amino-5-phosphonovaleric acid, phenytoin, and benzodiazepines.
D015763:2-Amino-5-phosphonovalerate; D000596:Amino Acids / Q000037:antagonists & inhibitors* / Q000494:pharmacology*; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D001224:Aspartic Acid / Q000494:pharmacology; D001569:Benzodiazepines; D001921:Brain / Q000187:drug effects*; D002540:Cerebral Cortex / Q000166:cytology / Q000187:drug effects; D005971:Glutamates / Q000494:pharmacology; D008297:Male; D009474:Neurons / Q000187:drug effects; D010672:Phenytoin / Q000494:pharmacology*; D011712:Pyramidal Tracts / Q000166:cytology; D011760:Pyrrolidinones / Q000494:pharmacology; D051381:Rats
D000596:Amino Acids; D014151:Anti-Anxiety Agents; D005971:Glutamates; D011760:Pyrrolidinones; D001569:Benzodiazepines; D001224:Aspartic Acid; D010672:Phenytoin; D015763:2-Amino-5-phosphonovalerate; C001369:1-hydroxy-3-amino-2-pyrrolidone